DD209818A5 - Verfahren zur herstellung von 5-phenylpyrazin-2-on-verbindungen und ihren salzen - Google Patents
Verfahren zur herstellung von 5-phenylpyrazin-2-on-verbindungen und ihren salzen Download PDFInfo
- Publication number
- DD209818A5 DD209818A5 DD25173683A DD25173683A DD209818A5 DD 209818 A5 DD209818 A5 DD 209818A5 DD 25173683 A DD25173683 A DD 25173683A DD 25173683 A DD25173683 A DD 25173683A DD 209818 A5 DD209818 A5 DD 209818A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- general formula
- compound
- preparation
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8216437 | 1982-06-05 | ||
| GB838300476A GB8300476D0 (en) | 1983-01-08 | 1983-01-08 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD209818A5 true DD209818A5 (de) | 1984-05-23 |
Family
ID=26283037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD25173683A DD209818A5 (de) | 1982-06-05 | 1983-06-03 | Verfahren zur herstellung von 5-phenylpyrazin-2-on-verbindungen und ihren salzen |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US4556711A (OSRAM) |
| EP (1) | EP0096517A3 (OSRAM) |
| KR (1) | KR840005111A (OSRAM) |
| AU (1) | AU1527583A (OSRAM) |
| DD (1) | DD209818A5 (OSRAM) |
| DK (1) | DK247783A (OSRAM) |
| ES (2) | ES522962A0 (OSRAM) |
| FI (1) | FI831998L (OSRAM) |
| GR (1) | GR79299B (OSRAM) |
| JO (1) | JO1255B1 (OSRAM) |
| NO (1) | NO832016L (OSRAM) |
| PL (1) | PL242354A1 (OSRAM) |
| PT (1) | PT76791B (OSRAM) |
| RO (1) | RO86851B (OSRAM) |
| ZW (1) | ZW12783A1 (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4657906A (en) * | 1982-06-05 | 1987-04-14 | Smith Kline & French Laboratories Ltd. | Heterocyclic compounds having inotropic activity |
| GB8332313D0 (en) * | 1983-12-02 | 1984-01-11 | Smith Kline French Lab | Chemical compounds |
| US4697016A (en) * | 1984-10-26 | 1987-09-29 | Ciba-Geigy Corporation | Intermediates for the preparation of a carboxylic acid |
| US4595766A (en) * | 1984-10-26 | 1986-06-17 | Ciba-Geigy Corporation | Process for the preparation of an indoline carboxylic acid |
| JPS62198671A (ja) * | 1986-02-25 | 1987-09-02 | Toyo Jozo Co Ltd | １−置換アルキル１，２−ジヒドロ−２−ピラジノン誘導体 |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| MX2012001974A (es) * | 2009-08-19 | 2012-04-11 | Ambit Biosciences Corp | Compuestos de biarilo y metodos de uso de los mismos. |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EA201391254A1 (ru) | 2011-03-01 | 2014-02-28 | Синерджи Фармасьютикалз Инк. | Способ получения агонистов гуанилатциклазы c |
| CN104718201A (zh) | 2012-06-12 | 2015-06-17 | 艾伯维公司 | 吡啶酮和哒嗪酮衍生物 |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| PL3004138T3 (pl) | 2013-06-05 | 2024-07-29 | Bausch Health Ireland Limited | Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie |
| EP3030252B1 (en) | 2013-08-09 | 2018-11-07 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス， インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3745161A (en) * | 1970-04-20 | 1973-07-10 | Merck & Co Inc | Phenyl-hydroxy-pyrazine carboxylic acids and derivatives |
-
1983
- 1983-05-27 EP EP83303059A patent/EP0096517A3/en not_active Withdrawn
- 1983-06-01 PT PT76791A patent/PT76791B/pt unknown
- 1983-06-01 AU AU15275/83A patent/AU1527583A/en not_active Abandoned
- 1983-06-01 JO JO19831255A patent/JO1255B1/en active
- 1983-06-01 DK DK247783A patent/DK247783A/da not_active Application Discontinuation
- 1983-06-01 GR GR71530A patent/GR79299B/el unknown
- 1983-06-02 US US06/500,486 patent/US4556711A/en not_active Expired - Lifetime
- 1983-06-02 US US06/500,484 patent/US4514568A/en not_active Expired - Fee Related
- 1983-06-03 PL PL24235483A patent/PL242354A1/xx unknown
- 1983-06-03 ZW ZW127/83A patent/ZW12783A1/xx unknown
- 1983-06-03 DD DD25173683A patent/DD209818A5/de unknown
- 1983-06-03 FI FI831998A patent/FI831998L/fi not_active Application Discontinuation
- 1983-06-03 RO RO111170A patent/RO86851B/ro unknown
- 1983-06-03 NO NO832016A patent/NO832016L/no unknown
- 1983-06-03 ES ES522962A patent/ES522962A0/es active Granted
- 1983-06-04 KR KR1019830002511A patent/KR840005111A/ko not_active Withdrawn
-
1984
- 1984-02-24 ES ES530024A patent/ES8707507A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NO832016L (no) | 1983-12-06 |
| ZW12783A1 (en) | 1983-08-24 |
| PT76791A (en) | 1983-07-01 |
| ES8500244A1 (es) | 1984-10-01 |
| GR79299B (OSRAM) | 1984-10-22 |
| PL242354A1 (en) | 1984-12-17 |
| PT76791B (en) | 1986-01-24 |
| EP0096517A2 (en) | 1983-12-21 |
| KR840005111A (ko) | 1984-11-03 |
| ES530024A0 (es) | 1985-12-01 |
| ES8707507A1 (es) | 1985-12-01 |
| US4556711A (en) | 1985-12-03 |
| US4514568A (en) | 1985-04-30 |
| RO86851B (ro) | 1985-05-31 |
| FI831998A0 (fi) | 1983-06-03 |
| FI831998A7 (fi) | 1983-12-06 |
| EP0096517A3 (en) | 1985-04-03 |
| DK247783D0 (da) | 1983-06-01 |
| DK247783A (da) | 1983-12-06 |
| ES522962A0 (es) | 1984-10-01 |
| FI831998L (fi) | 1983-12-06 |
| AU1527583A (en) | 1983-12-08 |
| JO1255B1 (en) | 1985-04-20 |
| RO86851A (ro) | 1985-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD209818A5 (de) | Verfahren zur herstellung von 5-phenylpyrazin-2-on-verbindungen und ihren salzen | |
| DE602004010848T2 (de) | Derivate von 1-piperazin- und 1-homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms | |
| EP0726899B1 (de) | Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln | |
| DE3781845T2 (de) | Benzimidazol-derivate. | |
| EP0175363B1 (de) | 4, 5-Dihydro-3(2H)-pyridazinone, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DD211555A5 (de) | Verfahren zur herstellung neuer 4-amino-6,7-dimethoxychinolin-derivate | |
| DD202152A5 (de) | Verfahren zur herstellung von phenylpiperazinderivaten | |
| DE60006054T2 (de) | Herstellungsverfahren für Pyridinderivate | |
| EP0117403A1 (de) | 6-(Acylaminoaryl)-3(2H)-pyridazinonderivate, ihre Herstellung und Verwendung | |
| DE2825906A1 (de) | 3-(pyrazol-1'-yl)-pyridazinderivate, solche enthaltende arzneimittel und verfahren zur herstellung derselben | |
| DD286581A5 (de) | Verfahren zur herstellung von hetera-aliphatischem carbonsaeureamiden | |
| DE2224338A1 (de) | Oxadiazol Derivate | |
| DE3027106C2 (OSRAM) | ||
| EP0018360B1 (de) | N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung | |
| DE2806661A1 (de) | Substituierte harnstoffe und verfahren zu ihrer herstellung | |
| DE2356239A1 (de) | Benzophenon-derivate und verfahren zu ihrer herstellung | |
| EP0224159B1 (de) | Neue basisch substituierte Pyridinverbindungen, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel und ihre Verwendung | |
| DE2215943A1 (de) | Neue 6-Phenyl-4H-s-triazolo eckige Klammer auf 1,5-a eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu benzodiazepin-2-carbonsäuren und ihre Ester, sowie Verfahren zu deren Herstellung | |
| US4657906A (en) | Heterocyclic compounds having inotropic activity | |
| DE2725019A1 (de) | Verfahren zur herstellung substituierter aminochinazolinderivate und zwischenprodukte dafuer | |
| HU206090B (en) | Process for producing new 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| DE2206890A1 (de) | Substituierte Methoxyaminderivate, ihre Verwendung und Verfahren zur Herstellung von substituierten Methoxyaminderivaten | |
| DE2854112A1 (de) | Neue pyrido-pyrimidine, verfahren zu ihrer herstellung und diese verbindungen enthaltenden arzneimittel | |
| CH647497A5 (en) | Process for the preparation of O-substituted hydroxylamines | |
| DE4239540A1 (de) | Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung |